Merck & Co - International Biopharmaceutical Industry

Current Edition

news

Gilead, following Merck, hits its own safety setback in HIV

The clinical hold comes at an inopportune time for Gilead. Last month, the company's longtime rival Merck & Co. disclosed worrisome findings from a study testing...

7 January 2022 news Gilead | HIV

Continue Reading →

news

In final analysis, Pfizer’s COVID-19 pill remains highly effective

Final study results show Pfizer's experimental COVID-19 pill remained as effective as indicated by preliminary data last month, a major relief after promising data fo...

15 December 2021 news COVID-19 pill | data

Continue Reading →

news

New Merck study results raise questions about its COVID pill

Final trial data for molnupiravir were less convincing than what Merck previously reported and could alter how the FDA views the drug. New study results disclosed by...

3 December 2021 news COVID-19 pill | Food and Drug Administration

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Gilead, following Merck, hits its own safety setback in HIV

In final analysis, Pfizer’s COVID-19 pill remains highly effective

New Merck study results raise questions about its COVID pill

International Biopharmaceutical Industry